Hy2Care BV develops a novel technology platform consisting of injectable hydrogels to fight osteoarthritis
Hy2Care has raised €14M across 3 funding rounds from 4 investors, most recently a round in May 2025. Based in Enschede, Netherlands; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-05-16 | Other | €4.5M | Brightlands Venture Partners,European Innovation Council (EIC) Fund,LIOF | View deal → |
| 2022-07-12 | Grant | €6.0M | EIC Accelerator | View deal → |
| 2019-04-01 | Series A | €3.7M | Brightlands Venture Partners | View deal → |
